The Patent Finder

RDD Pharma Ltd.

Also on record
Records under this name other than patents RDD Pharma Ltd. holds now: patents now held by others, patents whose terms have ended, and its applications, pending or abandoned.

Showing 1 to 6 of 6 · Back to RDD Pharma Ltd.

PatentTitleStatus Expires Confidence
US 9,849,114Oxymetazoline for the treatment of ano-rectal disorders
Formerly held
In force
 · From the USPTO record
In forceFrom the USPTO record
US 8,686,040Method for treating anal pruritis and other perianal disorders
Formerly held
Lapsed on the fee record
Ended Apr 1, 2026 · From the USPTO record
Lapsed on the fee recordEnded Apr 1, 2026From the USPTO record
US 10,821,274Methods and devices for delivery of pharmaceutical agents within orifices of the body
Lapsed on the fee record
Ended Nov 3, 2024 · From the USPTO record
Lapsed on the fee recordEnded Nov 3, 2024From the USPTO record
US 8,734,826Device and method for treating the anal sphincter
Lapsed on the fee record
Ended May 27, 2022 · From the USPTO record
Lapsed on the fee recordEnded May 27, 2022From the USPTO record
US 8,715,706Methods and devices for delivery of pharmaceutical agents within orifices of the body
Lapsed on the fee record
Ended May 6, 2022 · From the USPTO record
Lapsed on the fee recordEnded May 6, 2022From the USPTO record
US 9,937,136Methods for treating radiation induced gastrointestinal tract injury
Lapsed on the fee record
Ended Apr 10, 2022 · From the USPTO record
Lapsed on the fee recordEnded Apr 10, 2022From the USPTO record
The Patent Finder CompaniesExpirationsCalculatorWatchlistPricing MethodologyCorrectionsLegalPrivacysupport@thepatentfinder.com Updated Nov 18, 2026 · includes USPTO assignment data published Nov 17, 2026, status data published Nov 18, 2026 and grant & fee data published Nov 17, 2026 (weekly) Part of 137 Finder · © 2026 137 Finder LLC · Sources cited